- GLP-1 receptor agonists like Ozempic and Wegovy, originally intended as diabetes medications, have gained popularity for weight loss, leading to global shortages despite having modest benefits
- Research shows these drugs reduce seizures and substance addiction risks, but they increase the likelihood of 19 other health conditions, including fainting, kidney problems and pancreatic issues
- Common side effects include nausea, diarrhea, vomiting and abdominal pain, with potential risks of acute pancreatitis and thyroid cancer, making the trade-off dangerous for users
- Ozempic’s manufacturer Novo Nordisk reported $40.6 billion in revenue, highlighting how the “magic pill” mentality and ultraprocessed food consumption create a profitable cycle for pharmaceutical companies and food manufacturers
- Instead of relying on weight loss drugs, focus on optimizing cellular energy production through dietary changes, avoiding vegetable oils and supporting your gut and mitochondrial health
By now, most people around the world have heard of Ozempic and Wegovy, which are GLP-1 receptor agonists. These drugs, originally made for treating Type 2 diabetes, cause rapid weight loss, thus attracting individuals who have been struggling to lose weight for a long time. In fact, the effectiveness of these drugs has led to a global shortage.1 However, as with many other drugs that promise immediate results, there’s a catch.
Ozempic Hailed as a ‘Miracle Drug,’ but the Downsides Are Sinister
A report from The Epoch Times2 covered a study published in Nature Medicine,3 showing the impact of certain GLP-1 receptor agonists, sold under brand names such as Ozempic and Wegovy. As noted by The Epoch Times, “The media, patients, and even some doctors have dubbed the medications ‘miracle drugs’ because of their profound weight-loss effects.”4
In addition to weight loss, the study also noted that these drugs also lower the risk of “seizures and addiction to substances such as alcohol, cannabis, stimulants and opioids.”5 It’s believed that these drugs affect the brain’s neurological pathways related to reward and impulse control, explaining how these changes in behavior occur.6
Despite these benefits, the researchers caution potential, as there’s a dark side to these drugs that mainstream media and Big Pharma do not want you to see. According to the report, Ozempic increases your risk of developing a slew of other serious health conditions:7
“Researchers warn that these benefits come with an increased risk of 19 health conditions, such as syncope (fainting), arthritic disorders, and kidney and pancreatic problems.”
Similarly, a 2022 study found that commonly reported problems include nausea, diarrhea, vomiting and abdominal pain. An increased risk for acute pancreatitis and thyroid cancer was also noted.8 Meanwhile, Nature Medicine claims the benefits are “modest” at best:9
“While GLP-1RA drugs display effectiveness against a wide array of health problems, the magnitude of associated benefits is modest — about a 10% to 20% reduction for most outcomes.”
A Closer Look at the Research
The Nature Medicine study analyzed 215,970 diabetics using GLP-1 receptor agonists and compared them to multiple control groups: 159,465 taking sulfonylureas, 117,989 using DPP-4 inhibitors, and 258,614 on SGLT2 inhibitors. An additional control group of 536,068 used all three medications, while a separate baseline group of 1,203,097 received only standard care.10
They then produced a master list of health outcomes related to GLP-1 agonist receptor usage. As noted by The Epoch Times, while these drugs produced benefits, there were also significant adverse health outcomes:11
“Compared to usual care, GLP-1RA use was associated with a reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimer’s disease and dementia), coagulation disorders, cardiometabolic disorders, infectious illnesses and several respiratory conditions.
There was an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, nephrolithiasis, interstitial nephritis and drug-induced pancreatitis associated with GLP-1RA use compared to usual care. The results provide insights into the benefits and risks of GLP-1RAs and may be useful for informing clinical care and guiding research agendas.”
In a report by GoodRx, Stacia Woodcock, PharmD., outlines the mechanisms that lead to weight loss and other supposed benefits related to taking these drugs:12
- Hand-curated links from conservative and Christian sites — NO legacy media garbage links. Patriots get their news every day at JDRucker.com
- They signal your pancreas to release more insulin — After a meal, your blood glucose levels go up. Usually, the pancreas releases insulin when this happens to lower blood glucose levels. But in Type 2 diabetics, the body doesn’t always release enough. Incretin mimetics work on the pancreas to help raise insulin levels after you eat, which then lowers your blood glucose level.
- They increase your body’s sensitivity to insulin — Your body may also not respond as well to insulin if you’re diabetic. Incretin mimetics help increase insulin sensitivity, so your body can respond better to insulin when it’s released.
- They tell your liver to stop making glucose — This helps stop the production of new glucose to keep blood levels down.
The Cycle of Ultraprocessed Food and Ozempic Wrecks Public Health
As the weight-loss effects of GLP-1 receptor agonists gained widespread attention, Big Pharma’s profits in this market skyrocketed. According to The New York Times, Novo Nordisk, the maker of Ozempic and Wegovy, reported $40.6 billion in revenue in 2024; this figure is expected to jump by 16% to 24% in 2025.13
In the Tucker Carlson Show interview featured above, Dr. Casey Means, a Stanford-educated surgeon now focusing on functional medicine, expounds on the idea that a “magic pill” that causes weight loss and other supposed benefits appeals to millions of users:14
“I think it’s very dark. It’s a stranglehold on the U.S. population. Almost like solidifying this idea that there is a magic pill — I mean, literally, the book by Johann Ari is called ‘Magic Pill’ — and convincing us that, you know, salvation from our chronic health issues is going to be found in a shot when we are living in a toxic stew that’s destroying our cellular biology.”
Elsewhere in the interview, Means shares how ultraprocessed food contributes to obesity, thus cycling back to taking drugs that cause weight loss. In the end, only Big Pharma and Big Food are the real winners here, as millions of adults struggle with the damage they cause:15
“We are the only species in the world that has an obesity and chronic disease epidemic, the only species in the world that has a chronic disease and obesity epidemic because of ultraprocessed food.
You think about every other animal in the wild — they’re eating real, natural foods except for domesticated animals, which are also getting chronic diseases just like humans because they’re eating our food. But every other animal, they’re able to regulate their satiety. They’re not eating themselves to death like we are. We’re literally eating ourselves to death …
This could be on track to be the most profitable medication ever in human history. It will be if the powers that be let it. And what the unfortunate part is that it doesn’t take our bodies out of the toxic stew that’s crushing our biology. Yes, we may melt some fat and muscle without changing any of the other levers that we just talked about that are crushing our biology. So, this is not the public health solution.”
Practical Ways to Address Underlying Metabolic Challenges
I believe the key to maintaining a healthy weight is optimizing your cellular energy production. This requires a multifaceted approach that takes effort to implement, but it leads to safer, healthier results — something GLP-1 receptor agonists don’t offer. With that in mind, here are my recommendations:
1.Avoid Ozempic and other GLP-1 agonist receptor drugs — The most obvious strategy is avoiding GLP-1 agonist receptors in the first place. If you’re tempted to start, you owe it to yourself to read the study to understand the dangers.
Pills and injections offer short-term relief, but they often mask deeper imbalances in how your cells produce and use energy. Real improvement happens when you remove the factors that strain your metabolism rather than rely on a drug to force quick weight loss.
2.Remove vegetable oils from your diet — If you regularly consume ultraprocessed foods, I recommend stopping right now and replacing them with real, whole foods. Processed foods contain linoleic acid-rich vegetable oils that disrupt your metabolic pathways and alter how your body stores fat. Instead, cook your meals using tallow, grass fed butter or coconut oil.
To protect your health from further damage, limit your intake of linoleic acid to less than 5 grams per day from all sources. I recommend using Cronometer, an online food tracker, so you don’t go over this recommended range.
3.Shift your carbohydrate sources gradually — Avoid making sudden dietary changes that can shock your system. If your gut is compromised, start by introducing easily digestible carbohydrates like whole fruit or white rice before incorporating more complex carbs.
For severe gut issues, sip dextrose water throughout the day as a temporary aid to support healing, but limit its use to about two weeks. The goal is to provide your cells with a steady source of easy-to-digest, healthy carbohydrates for energy.
4.Consider your protein and collagen intake — I suggest aiming for 0.8 grams of protein per pound of lean body mass and balancing that amount so that about one-third comes from collagen. Doing this supports muscle maintenance, tissue repair and hormone balance.
If you exercise frequently, you would probably do well with a higher intake, but take it slow and listen to how your body responds. Stable protein intake is foundational for regulating cravings and stabilizing energy.
5.Support your gut and mitochondrial health with other healthy habits — I recommend getting daily sunlight exposure while being mindful of timing. If your diet previously included vegetable oils, avoid intense midday sun for at least six months to reduce the risk of sunburn and skin damage. Additionally, grounding in low-EMF environments can be beneficial if available — oceans, particularly in North America, tend to be the safest option.
In addition, moderate-intensity movement, such as walking, supports cellular energy production and aids in weight management. Gradual, consistent effort in these areas strengthens your metabolism and leads to lasting health improvements. I believe this approach is far superior to relying on a so-called “magic” drug like Ozempic.
Boost Your GLP-1 Naturally with Akkermansia
The idea of a quick-fix pill may be tempting, but it comes at a long-term cost to your health. A better approach is to naturally boost your GLP-1 levels by supporting Akkermansia, a beneficial gut probiotic that produces a GLP-1-inducing protein. As noted in one study:16
“A. muciniphila increases thermogenesis and glucagon-like peptide-1 (GLP-1) secretion in high-fat-diet (HFD)-induced C57BL/6J mice by induction of uncoupling protein 1 in brown adipose tissue and systemic GLP-1 secretion.”
Many people lack Akkermansia due to various reasons, such as impaired mitochondrial function or an environment that is inhospitable to beneficial gut bacteria. Ideally, Akkermansia should comprise 3% to 5% of your total gut microbiome and it plays many different roles aside from promoting GLP-1.
For example, Akkermansia has the ability to produce mucin, which is a thick, gel-like substance that protects the gut lining from harmful pathogens, irritation from stomach acid and enzymes, as well as mechanical damage. Moreover, mucin helps nourish the gut bacteria already existing in your gut.
To boost Akkermansia naturally, eat plenty of berries and inulin-rich foods such as garlic, asparagus, bananas and leeks. Note, however, that if your gut health is currently out of whack, introducing high amounts of dietary fiber in your system all at once can worsen your gastrointestinal symptoms. So, work on healing your gut first, then gradually increase fiber intake.
- 1, 15 JAMA Netw Open. 2024 Aug 20;7(8):e2423385
- 2, 4, 5, 6, 7 The Epoch Times, January 28, 2025
- 3, 10, 11 Nat Med. 2025 Jan 20
- 8 Front Public Health. 2022 Oct 20;10:996179
- 9 WashU Medicine, January 20, 2025
- 12 GoodRX, October 2, 2023
- 13 The New York Times, February 5, 2025
- 14 YouTube, Tucker Carlson, August 17, 2024
- 16 Nature Microbiology volume 6, pages 563–573 (2021)
Bypass Big Tech Censors
Two Storms, One Harvest
Every food crisis in living memory has been a one-shock event. The 2008 price spike was a commodity bubble. The 2020 shortages were a logistics failure. The 2022 grain scare was a war on one exporter’s ports. Each time, the system bent, adjusted, and recovered, and each time the experts assured us afterward that global markets are simply too big and too diversified to fail.
What nobody in Washington seems eager to discuss is that 2026 is shaping up to be something the modern food system has never actually faced. Two independent shocks, one climatic and one geopolitical, are converging on the same harvest cycle at the same time. Not sequentially. Simultaneously.
Start with the weather. The Pacific Ocean is currently building toward what forecasters now openly call a record event. NOAA’s Climate Prediction Center puts the odds of at least a strong El Niño near 88 percent, with roughly two in three odds it reaches “very strong” status, the tier reserved for perhaps three or four events in the entire satellite era. Every major global model now projects a median peak in Super El Niño territory, and most of them project it exceeding the 2015-16 event, which until now held the modern record. Sea surface anomalies were already brushing the super threshold in mid-July, months before these events normally peak. The atmosphere has already shifted into El Niño mode, and the event is forecast to crest in late fall and early winter.
This is not about “climate change.” It’s about the standard cycles of weather, and the cycle we’re currently in is one that has likely devastated societies in the past. We’re better prepared as a society today, but not all Americans are equally prepared.
Serious households have started doing the quiet math on their own. Grocery bills tell part of the story, and the forecast maps tell the rest, which is why long-term food storage has moved from fringe hobby to mainstream line item in the family budget, with established suppliers like Heaven’s Harvest seeing demand from people who five years ago would have rolled their eyes at the idea. That instinct is not paranoia. It is pattern recognition, and the pattern is worth walking through carefully.
Editor’s Note: Heaven’s Harvest IS a sponsor, but the warnings of this article are real and would be written even if we didn’t have a survival food sponsor. With that said, those who take advantage of what they offer can use promo code “Patriot” for 15% off.
The Fertilizer Clock Is Already Running
While the Pacific warms, the second shock has been unfolding in the Strait of Hormuz. The conflict with Iran turned the world’s most important energy chokepoint into a contested waterway, and the consequences reach far beyond the gas pump. Roughly a third of global fertilizer trade moves through Hormuz, and the disruption sent urea prices up 86 percent year over year by March, with a 53 percent jump in a single month.
The World Bank projects energy prices rising about 24 percent in 2026 and fertilizer about 31 percent. By its own accounting, fertilizer prices ran 35 percent higher in the first five months of this year than the same period last year.
Here is the mechanism the nightly news will not explain. Fertilizer is not a grocery item. It is a time-delayed input. The nitrogen a farmer in Iowa or Punjab could not afford to apply this spring does not show up as a problem this spring. It shows up as a thinner harvest six to twelve months later.
The World Bank’s own food security brief concedes that the effects of reduced applications earlier this season “are likely to become visible only later in harvest outcomes.” Translate that from institutional language into plain English and it means this. The damage is already done, it is already in the ground, and we are simply waiting for it to arrive on the shelf.
Now check the calendar. Six to twelve months from the spring planting season lands us squarely in late 2026 and early 2027. Which is precisely when the strongest El Niño in the instrumental record is forecast to peak, bringing its signature droughts to Southeast Asia, Australia, southern Africa, northern Brazil, and South Asia, the very regions that grow the world’s rice, sugar, and oilseeds.
The World Bank warns openly that a strong El Niño “could disrupt multiple crop belts simultaneously” on top of the conflict-driven input costs. Their baseline projection assumes the Middle East disruptions ease by autumn. What in the last two years of Middle East history suggests that assumption is safe?
The System Has No Slack Left
The comfortable answer is that global markets always adjust. But adjustment requires slack, and the slack is gone. Global cereal production is expected to decline from last year’s records even before El Niño does its work. The UN World Food Programme, hardly a den of right-wing preppers, is calling this the most significant disruption to its supply chains since Covid and the invasion of Ukraine, and its supply chain director put the stakes bluntly.
Today’s supply chain challenges are tomorrow’s hunger crisis.
There is also a political dimension that markets cannot price. When food gets scarce, governments do not behave like economists. They behave like politicians. Export bans, hoarding mandates, and panic buying at the national level turned the modest rice shortfall of 2008 into a global crisis, and analysts are already warning that import-dependent nations are the first dominoes.
The 2015-16 Super El Niño, a far weaker event than what is now forecast, threw tens of millions into food stress across Africa and Asia. This one is projected to be stronger, and it arrives with fertilizer already rationed by price and shipping lanes already contested by missiles.
What Joseph Knew
Scripture does not treat preparation for lean years as faithlessness. It treats it as wisdom delivered in advance to those willing to act on it.
Behold, there come seven years of great plenty throughout all the land of Egypt: And there shall arise after them seven years of famine; and all the plenty shall be forgotten in the land of Egypt.
Joseph did not respond to that warning with a hashtag or a committee. He stored grain during the years of abundance, and when the famine came, Egypt stood while its neighbors begged. The lesson is not that famine is certain. It is that the time to prepare is precisely when preparation still looks optional.
Nobody who filled a pantry in a year of plenty has ever regretted it, and nobody standing in an empty aisle has ever been glad he waited for certainty.
None of this calls for panic, and panic is the enemy of sound judgment anyway. It calls for the same unglamorous prudence our grandparents considered ordinary. Keep some cash margin, know your local growers, and put real food in deep storage while it is cheap and available, because the entire arc of this story is that cheap and available is a closing window.
Families looking for a straightforward place to start can visit Heaven’s Harvest and use promo code Patriot for 15 percent off long-term storable food. The forecasts may yet soften, the strait may yet reopen, and we should pray they do. But hope is a fine thing to hold and a foolish thing to eat.
Why don’t you be honest, yes there are adverse reactions IN SOME PEOPLE, but it has also been linked to many GOOD things as well.
1. 24% lower chance of having a major kidney disease event
2. Shows promise for treating chronic kidney disease,
3. Lowered the risk of major adverse cardiovascular events by 20%, the FDA also approved them to lower the odds of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and overweight or obesity.
4. A 2023 study showed that semaglutide lowered the rate of colorectal cancer—cancer affecting the large intestine or rectum—in people with type 2 diabetes.
5. Studies have suggested that people with type 2 diabetes who take GLP-1 receptor agonists, such as semaglutide, may have a lower rate of dementia compared to people given a placebo.
6. Research presented June 1 at the Endocrine Society’s meeting in Boston showed that semaglutide may lower the risk of acute pancreatitis, the sudden inflammation of the pancreas.
7. A small study published in 2023 suggested that semaglutide may lower symptoms of alcohol use disorder, which involves problems limiting alcohol intake.
8. to treat symptoms of polycystic ovary syndrome (PCOS), a hormone imbalance that usually occurs when a person has high-than-normal levels of androgens.
From Helth com “Beyond Weight Management: 5 Other Potential Benefits of Semaglutide”
Note: The article also states some problems with Semaglutide.
BS. I have seen it help VASTLY more people that this small sampling in this study shows, plus, how many of these people were using it way over the max 3mg per week? But yes, lets all get fat again with arthritis, kidney failure, fatty livers, high blood pressure and heart trouble. I am very very sure the health industry and big pharma would preferer that!